Assessment of AI digital innovation launch readiness & resolution of access barriers in China
Goal
Our client was preparing for a launch as first entrant into a rare disease with high occurrence of late or misdiagnoses. An innovative AI Digital Diagnosis Tool was prioritized as a strategic initiative critical to supporting earlier diagnosis at launch.
The global team selected China due to the ability to collect big health data and country willingness, vast rural areas to identify patients and strong in-house/3rd-party AI skills. As part of a broader launch excellence project, we needed to define the requirements, patient experience & readiness plan for the AI solution.